The global diabetic care market size is estimated at 41.80 billion USD with a CAGR of 7.2% during the forecasted period from 2021-2028.
The global diabetic care market size is estimated at 41.80 billion USD with a CAGR of 7.2% during the forecasted period from 2021-2028. Diabetes care devices are frequently used to regulate blood sugar levels in the body on account of insulin production.
The care is been offer for diabetic patients to efficiently monitor blood glucose levels and progress treatment for this chronic situation. Major drivers comprise international research partnership and the development of the diabetes-affected patient pool, government is taking initiatives to offer better health facilities and improved opportunities for other market companies.
Technological improvement in the market is a can give huge success to the market. The increasing needs for safe, fast, and effective procedures of treatment and diagnosis of diabetes a challenge in the market. The factors such as high price of diabetes care, effective substitute therapies are anticipated to restrict the market growth in the forecast period
The continuous innovation and advancement of new diabetes care technologies are developing a specific platform for the further enhancement of the diabetes care market. With the advent of advanced technologies such as precision medicine, mobile health, smart sensors, 3D printing, and wearable technology, the overall demand for newly developed diabetes care products is increasing. Currently, the main focus of government initiatives is to develop non-invasive solutions to control the growth of people with diabetes and integrate advanced technologies to meet the unmet needs of people with diabetes.Table of Content 1. Introduction 1.1. Executive Summary 1.2. Market Definition 1.3. Market Scope 2. Research Methodology 2.1.1. Primary Research 2.1.2. Research Methodology 2.1.3. Assumptions & Exclusions 2.1.4. Secondary data sources 3. Market Overview 3.1. Report Segmentation & Scope 3.2. Key Market Trend 3.3. Drivers 3.3.1. Increasing prevalence of diabetes across the globe. 3.3.2. Growing disposable income along with changing the lifestyle of the population. 3.3.3. Presence of best-quality healthcare infrastructure and system. 3.4. Restraints 3.4.1. Lack of healthcare professional and awareness regarding diabetes care management. 3.4.2. The high cost of diabetes treatment. 3.5. Opportunity 3.5.1. Governmental initiatives and regulations by providing modern mobile technologies to diabetic people. 3.5.2. Rising demand for technological advancement and innovation, non-invasive treatments, and improvement of the artificial pancreas. 3.6. Porter’s Five Forces Analysis 3.6.1. Porter’s Five Forces Analysis 3.7. Market Share Analysis 4. Type Overview 4.1. Introduction 4.1.1. Market Size & Forecast 4.2. Youth Onset Diabetes 4.2.1. Market Size & Forecast 4.3. Adult Onset Diabetes 4.3.1. Market Size & Forecast 4.4. Gestational Diabetes 4.4.1. Market Size & Forecast 5. End-User Overview 5.1. Introduction 5.1.1. Market Size & Forecast 5.2. Research Institute 5.2.1. Market Size & Forecast 5.3. Hospital 5.3.1. Market Size & Forecast 5.4. Home Care 5.4.1. Market Size & Forecast 6. Regional Overview 6.1. Introduction 6.1.1. Market Size & Forecast 6.2. North America 6.2.1. North America Market Size & Forecast, By Country 6.2.2. North America Market Size & Forecast, By Type 6.2.3. North America Market Size & Forecast, By End-User 6.2.4. The U.S. 6.2.4.1. Market Size and Forecast 6.2.5. Canada 6.2.5.1. Market Size and Forecast 6.2.6. Mexico 6.2.6.1. Market Size and Forecast 6.3. Europe 6.3.1. Europe Market Size & Forecast, By Country 6.3.2. Europe Market Size & Forecast, By Type 6.3.3. Europe Market Size & Forecast, By End-User 6.3.4. Germany 6.3.4.1. Market Size and Forecast 6.3.5. France 6.3.5.1. Market Size and Forecast 6.3.6. UK 6.3.6.1. Market Size and Forecast 6.3.7. Italy 6.3.7.1. Market Size and Forecast 6.3.8. Spain 6.3.8.1. Market Size and Forecast 6.3.9. Rest of Europe 6.3.9.1. Market Size and Forecast 6.4. Asia-Pacific 6.4.1. Asia-Pacific Market Size & Forecast, By Country 6.4.2. Asia-Pacific Market Size & Forecast, By Type 6.4.3. Asia-Pacific Market Size & Forecast, By End-User 6.4.4. Japan 6.4.4.1. Market Size and Forecast 6.4.5. China 6.4.5.1. Market Size and Forecast 6.4.6. Australia 6.4.6.1. Market Size and Forecast 6.4.7. India 6.4.7.1. Market Size and Forecast 6.4.8. South Korea 6.4.8.1. Market Size and Forecast 6.4.9. Rest of Asia-Pacific 6.4.9.1. Market Size and Forecast 6.5. Rest of the World 6.5.1. Rest of the World Market Size & Forecast, By Country 6.5.2. Rest of the World Market Size & Forecast, By Type 6.5.3. Rest of the World Market Size & Forecast, By End-User 6.5.4. South America 6.5.4.1. Market Size and Forecast 6.5.5. Middle East 6.5.5.1. Market Size and Forecast 6.5.6. Africa 6.5.6.1. Market Size and Forecast 7. Company Profile 7.1. AstraZeneca Pharmaceuticals LP 7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2. AstraZeneca Pharmaceuticals LP Product Category, Application, and Specification 7.1.3. AstraZeneca Pharmaceuticals LP Financial Performance (2016-2018) 7.1.4. Main Business/Business Overview 7.2. Bristol-Myers Squibb Co 7.3. Dexcom, Inc. 7.4. Eli Lily and Company 7.5. Johnson & Johnson Services, Inc. 7.6. Medtronic 7.7. Novo Nordisk A/S 7.8. Roche Diagnostics Ltd 7.9. Sanofi S.A. 7.10. Terumo Europe NV
(US)
